Mure 2018: about 50 percent of mammalian gene expression is rhythmic, and over half of FDA-approved drugs target rhythmic genes; chronotherapy can exploit timing windows.
Mure 2018: about 50 percent of mammalian gene expression is rhythmic, and over half of FDA-approved drugs target rhythmic genes; chronotherapy can exploit timing windows.